Symptomtext
received YF-VAX and had received another live vaccine 8 days earlier with no reported adverse event; Initial information received on 17-Apr-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 4 years old male patient who received Yellow Fever Vaccine [Yf-Vax] and had received another live vaccine 8 days earlier with no reported adverse event and patient also received Measles Vaccine, Mumps Vaccine, Rubella Vaccine (Mmr) The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Typhoid Vaccine (Typhoid) for Prophylactic vaccination. On 20-Mar-2023, the patient received an unknown dose of suspect MEASLES VACCINE, MUMPS VACCINE, RUBELLA VACCINE (MMR) not produced by Sanofi Pasteur (with an unknown formulation, lot number, expiry date, strength) via unknown route in unknown administration site for prophylactic vaccination (Immunisation). On 28-Mar-2023, the patient received 0.5 ml of suspect Yellow Fever Vaccine Solution for injection (lot number: UJ818AA; Expiry date: 18-Apr-2024) (Strength: Standard) (Frequency: once) via subcutaneous route in the left thigh for immunization. On 28-Mar-2023, the patient received Yellow Fever Vaccine and had received another live vaccine (latency: 1 day) earlier with no reported adverse event (inappropriate schedule of product administration) and MEASLES VACCINE, MUMPS VACCINE, RUBELLA VACCINE . It was reported, When not administered concomitantly, wait at least 4 weeks between administration of YF- Caller reporting a patient received YF-VAX and had received another live vaccine 8 days earlier. Caller with question on whether dose needs repeating. MMR administered on 20MAR2023 and YF-VAX administered on 28MAR2023.This situation is reported as a medication error due to not administering dose within guidelines on the PI in regard to waiting 4 weeks between administering Live vaccines. Action taken: not applicable for both the vaccines Outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.